Ladiratuzumab Biosimilar (LIV-1 / SLC39A6 Reference Antibody）

SKU: orb2703970

Description

Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer.

Images & Validation

−

Key Properties

−

Antibody Type	Biosimilar Antibody
Clonality	Monoclonal
Target	Ladiratuzumab Biosimilar（Anti-LIV-1 / SLC39A6 Reference Antibody）
Purity	>98%
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Ladiratuzumab Biosimilar（Anti-LIV-1 / SLC39A6 Reference Antibody）

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols